AWA
GILD icon

Arkadios Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Arkadios Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
104,200
+743
+0.7% +$97.9K 0.2% 106
2026
Q1 		$14.4M Buy
103,457
+56,837
+122% +$7.96M 0.24% 89
2025
Q4 		$5.72M Buy
46,620
+737
+2% +$89.6K 0.11% 199
2025
Q3 		$5.09M Sell
45,883
-2,168
-5% -$246K 0.12% 189
2025
Q2 		$5.33M Buy
48,051
+2,301
+5% +$245K 0.16% 144
2025
Q1 		$5.13M Buy
45,750
+22,240
+95% +$2.29M 0.19% 120
2024
Q4 		$2.17M Sell
23,510
-10,473
-31% -$943K 0.12% 169
2024
Q3 		$2.85M Sell
33,983
-4,141
-11% -$316K 0.16% 131
2024
Q2 		$2.62M Buy
38,124
+11,204
+42% +$748K 0.18% 124
2024
Q1 		$1.97M Sell
26,920
-571
-2% -$43.9K 0.15% 147
2023
Q4 		$2.23M Buy
27,491
+9,204
+50% +$716K 0.19% 119
2023
Q3 		$1.37M Buy
18,287
+14,456
+377% +$1.11M 0.13% 169
2023
Q2 		$295K Buy
3,831
+196
+5% +$15.6K 0.03% 451
2023
Q1 		$302K Buy
3,635
+34
+0.9% +$2.82K 0.04% 434
2022
Q4 		$309K Sell
3,601
-870
-19% -$68.9K 0.04% 395
2022
Q3 		$276K Buy
+4,471
New +$282K 0.04% 404
2021
Q4 		– Sell
-2,493
Closed -$174K – 1049
2021
Q3 		$174K Buy
2,493
+676
+37% +$47.5K 0.03% 540
2021
Q2 		$125K Buy
1,817
+1,224
+206% +$81.7K 0.02% 664
2021
Q1 		$38K Sell
593
-74
-11% -$4.77K 0.01% 768
2020
Q4 		$38K Sell
667
-70
-9% -$4.22K 0.01% 608
2020
Q3 		$45.7K Sell
737
-1,122
-60% -$77.8K 0.02% 436
2020
Q2 		$143K Buy
1,859
+159
+9% +$12.2K 0.08% 205
2020
Q1 		$127K Buy
1,700
+900
+113% +$62.2K 0.08% 199
2019
Q4 		$53.4K Buy
+800
New +$52.1K 0.03% 307

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arkadios Wealth Advisors's GILD Position: Q2 2026 in Review

Arkadios Wealth Advisors increased its Gilead Sciences (GILD) stake by 0.72% in Q2 2026, buying an estimated $97.9K and bringing the position to 104,200 shares worth $13.2M. The position accounts for 0.2% of the portfolio, ranked #106.

Arkadios Wealth Advisors first reported a position in GILD in Q4 2019 and has held it in 24 quarters since. The position peaked at $14.4M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Arkadios Wealth Advisors held 104,200 shares of Gilead Sciences worth $13.2M as of Q2 2026.
  • Arkadios Wealth Advisors bought 743 Gilead Sciences shares in Q2 2026, an estimated $97.9K.
  • Gilead Sciences made up 0.2% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #106 holding.
  • Arkadios Wealth Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 24 quarters since.
  • Arkadios Wealth Advisors's Gilead Sciences position peaked at $14.4M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.